Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ CardioTACS In Situ Apoptosis Detection Kit

Provides all the reagents for the detection of DNA fragmentation in cardiac cells and tissue sections along with a cation that specifically enhances the signal in apoptotic cardiac cells

Supplier:  R&D Systems™ 482730K

Catalog No. 482730K


Explore all special offers
Add to Cart

Includes: Cytonin™, 5mL; Proteinase K, 30uL; TACS Blue Label, 1.5mL; TACS-Nuclease, 15uL; Red Counterstain C, 50mL; Strep-HRP, 30uL; Also includes TdT enzyme, buffers and dNTPs, 50X Mn+2; Other reagents
This item is not returnable. View return policy

Description

Description

Apoptosis is characterized by a number of intracellular phenomena such as membrane blebbing, chromatin condensation and nuclear DNA fragmentation. Detection of nuclear DNA fragmentation is a widely accepted method to assay for apoptosis and can be perform

Complete kits contain TACS BlueLabel™, Nuclear Fast Red counterstain and reagents necessary for generating positive controls
Kits are optimized for detection of apoptosis in cardiac tissues
Study fixed cells, embedded tissues and froze

Specifications

Specifications

30 Tests
The product requires storage at -20 to -70° C, 2 - 8° C, and room temperature. Consult the product insert for specific storage temperatures. Do not use past expiration date.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.